Presented at Digital Pathology & AI Congress Europe 2025.
Quantitative Digital Pathology workflows are playing an increasingly important role across Pharma R&D, improving data quality, supporting remote collaboration, and enabling the application of AI-powered image analysis. As study workloads scale, standardised QC, interoperability, and structured data handling are becoming essential to maintain reliable outcomes.
OracleBio presented how AI tools and Python scripting can strengthen internal Quantitative Digital Pathology pipelines, reducing manual effort, improving QC steps, and supporting more consistent execution across complex studies.
What you’ll learn:
- Incoming images undergo virus scanning, file integrity checks, and metadata validation before analysis to ensure accuracy at the start of the workflow.
- Brightfield and multiplex staining issues are flagged using HALO Stain QC and a Python-based QC tool, supporting interoperability across image analysis platforms.
- A browser-based data curation tool enables scientists to edit fields, apply formulas, and perform QC checks at scale, reducing spreadsheet overhead and improving data consistency.
Click the thumbnail above to download the full poster and see how OracleBio is applying digital pathology and AI-supported workflows to improve the efficiency of R&D studies.
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more
You might also like these Posters:
Analysis of the contribution of macrophages to the overall tumor PD-L1 microenvironment using a screening multi-tumor tissue microarray and rapid multiplex fluorescence digital phenotyping approach
OracleBio analysis data is presented at at American Society of Clinical Oncology (ASCO) in June 2022. The poster, presented by Marie Cumberbatch from TriStar Technology Group, is collaborative work between TriStar, Ultivue, and OracleBio. The work involved multiplex...
Utilizing Quantitative Digital Pathology techniques for analysis of Hepatitis B liver samples stained with a 12-plex multiplex-IF assay
OracleBio data is presented at the 8th Digital Pathology & AI Congress: USA 2022 in New York. The poster, produced in collaboration with Gilead, involved a comprehensive evaluation of Hepatitis B liver samples stained using a 12-plex assay, with this poster...
A Quantitative Digital Pathology Workflow to Manage Technical Challenges within Multiplex IF R&D Studies
This poster, created in collaboration with Bristol Myers Squibb, details OracleBio's robust image analysis workflow in Indica Labs HALO, and how it helped overcome common technical issues encountered in a large multiplex IF (mIF) non-small cell lung cancer (NSCLC)...
